C19H20FNO3.ClH
Neat
365.83
Paroxetine Related Compound C
Paroxetine impurity D CRS
+5°C
Room Temperature
Paroxetine Imp. D (EP), Paroxetine Hydrochloride Anhydrous Imp. D (EP), Paroxetine USP Related Compound C, Paroxetine USP RC C, (3R, 4S)-3-[(1, 3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride, Piperidine, 3-[(1, 3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R, 4S)- (9CI), Piperidine, 3-[(1, 3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R-trans)-, Paroxetine Related Compound C (USP), (+)-trans-Paroxetine Hydrochloride, BRL-29679A, USP Paroxetine Hydrochloride Related Compound C, Ph Eur Paroxetine Hydrochloride Impurity D, Paroxetine Related Compound C as Hydrochloride, Paroxetine Hydrochloride Hemihydrate Impurity D as Hydrochloride, Paroxetine Hydrochloride Impurity D as Hydrochloride, Paroxetine Impurity D as Hydrochloride and Paroxetine Impurity D as Hydrochloride
Cl.Fc1ccc(cc1)[C@H]2CCNC[C@@H]2COc3ccc4OCOc4c3
(3R, 4S)-3-(1 and 3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride